A Study to Examine the Efficacy and Safety of Anti-Fel d 1 Antibodies Injections in Cat-allergic Adolescent and Adult Patients With Allergic Rhinitis Who Live With a Cat
Clinical trial NCT04981717 · TERMINATED
Trial details
- NCT number
- NCT04981717
- Sponsor
- Regeneron Pharmaceuticals
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-07-30
- Primary completion
- 2023-01-04
- Enrollment
- 446
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.